0001127602-18-027101.txt : 20180907 0001127602-18-027101.hdr.sgml : 20180907 20180907161554 ACCESSION NUMBER: 0001127602-18-027101 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180906 FILED AS OF DATE: 20180907 DATE AS OF CHANGE: 20180907 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CAUSEY CHRISTOPHER CENTRAL INDEX KEY: 0001237334 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-26301 FILM NUMBER: 181060326 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: UNITED THERAPEUTICS Corp CENTRAL INDEX KEY: 0001082554 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 521984749 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1040 SPRING ST CITY: SILVER SPRING STATE: MD ZIP: 20910 BUSINESS PHONE: 3016089292 MAIL ADDRESS: STREET 1: 1040 SPRING ST CITY: SILVER SPRING STATE: MD ZIP: 20910 FORMER COMPANY: FORMER CONFORMED NAME: UNITED THERAPEUTICS CORP DATE OF NAME CHANGE: 19990324 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2018-09-06 0001082554 UNITED THERAPEUTICS Corp UTHR 0001237334 CAUSEY CHRISTOPHER C/O UNITED THERAPEUTICS CORPORATION 1040 SPRING STREET SILVER SPRING MD 20910 1 Common Stock 2018-09-06 4 M 0 750 54.77 A 3925 D Common Stock 2018-09-06 4 D 0 750 118.48 D 3175 D Common Stock 2018-09-06 4 S 0 810 118.00 D 2365 D Share Tracking Award 54.77 2018-09-06 4 M 0 750 0 D 2012-06-29 2021-06-29 Common Stock 750 1500 D This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. This transaction was executed in multiple trades at prices ranging from $118.00 to $118.03. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. /s/ John S. Hess, Jr. under Power of Attorney 2018-09-07